polyDNA has learned that Gilead Sciences’ new drug against hepatitis C “is so effective, Wall Street analysts say, that it’s possible public health officials could begin thinking about eradicating the liver-damaging virus (1).” However, the high cost of the drug, which is reported to be $ 1,000 per pill and $ ...
No comments:
Post a Comment